Legis Daily

United States Anti-Doping Agency Reauthorization Act of 2020

USA116th CongressS-3248| Senate 
| Updated: 12/18/2020
Jerry Moran

Jerry Moran

Republican Senator

Kansas

Cosponsors (1)
Richard Blumenthal (Democratic)

Commerce, Science, and Transportation Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
United States Anti-Doping Agency Reauthorization Act of 2020 This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029. USADA shall serve as the independent anti-doping organization for the amateur athletic competitions recognized by the U.S. Olympic and Paralympic Committee, be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within U.S. jurisdiction, and be recognized worldwide as the independent national anti-doping organization for the United States. Any administrative action taken by USADA to enforce a USADA policy, procedure, or requirement against a person with respect to a violation of federal law shall be carried out in a manner that provides due process protection to the person. The bill also directs (1) USADA to promote a positive youth sport experience by providing educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 3, 2020
Introduced in Senate
Feb 3, 2020
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Mar 11, 2020
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment favorably.
Sep 30, 2020

Latest Companion Bill Action

HR 116-5373
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Nov 17, 2020
Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.
Nov 17, 2020
Placed on Senate Legislative Calendar under General Orders. Calendar No. 594.
Dec 17, 2020
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7642)
Dec 17, 2020
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
Dec 17, 2020
Measure laid before Senate by unanimous consent. (consideration: CR S7641-7642)
Dec 17, 2020
The committee amendments withdrawn by Unanimous Consent. (CR S7641)
Dec 18, 2020
Message on Senate action sent to the House.
Dec 18, 2020
Received in the House.
Dec 18, 2020
Held at the desk.
  • February 3, 2020
    Introduced in Senate


  • February 3, 2020
    Read twice and referred to the Committee on Commerce, Science, and Transportation.


  • March 11, 2020
    Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment favorably.


  • September 30, 2020

    Latest Companion Bill Action

    HR 116-5373
    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.


  • November 17, 2020
    Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.


  • November 17, 2020
    Placed on Senate Legislative Calendar under General Orders. Calendar No. 594.


  • December 17, 2020
    Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7642)


  • December 17, 2020
    Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.


  • December 17, 2020
    Measure laid before Senate by unanimous consent. (consideration: CR S7641-7642)


  • December 17, 2020
    The committee amendments withdrawn by Unanimous Consent. (CR S7641)


  • December 18, 2020
    Message on Senate action sent to the House.


  • December 18, 2020
    Received in the House.


  • December 18, 2020
    Held at the desk.

Sports and Recreation

Related Bills

  • HR 116-5373: United States Anti-Doping Agency Reauthorization Act of 2020
Alternative dispute resolution, mediation, arbitrationAthletesChild healthCongressional oversightCriminal investigation, prosecution, interrogationDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDue process and equal protectionInternational law and treatiesInternational organizations and cooperationMammalsMedical tests and diagnostic methodsOlympic gamesVeterinary medicine and animal diseases

United States Anti-Doping Agency Reauthorization Act of 2020

USA116th CongressS-3248| Senate 
| Updated: 12/18/2020
United States Anti-Doping Agency Reauthorization Act of 2020 This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2029. USADA shall serve as the independent anti-doping organization for the amateur athletic competitions recognized by the U.S. Olympic and Paralympic Committee, be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within U.S. jurisdiction, and be recognized worldwide as the independent national anti-doping organization for the United States. Any administrative action taken by USADA to enforce a USADA policy, procedure, or requirement against a person with respect to a violation of federal law shall be carried out in a manner that provides due process protection to the person. The bill also directs (1) USADA to promote a positive youth sport experience by providing educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports; and (2) the Department of Justice, the Department of Homeland Security, and the Food and Drug Administration to provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 3, 2020
Introduced in Senate
Feb 3, 2020
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Mar 11, 2020
Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment favorably.
Sep 30, 2020

Latest Companion Bill Action

HR 116-5373
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Nov 17, 2020
Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.
Nov 17, 2020
Placed on Senate Legislative Calendar under General Orders. Calendar No. 594.
Dec 17, 2020
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7642)
Dec 17, 2020
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
Dec 17, 2020
Measure laid before Senate by unanimous consent. (consideration: CR S7641-7642)
Dec 17, 2020
The committee amendments withdrawn by Unanimous Consent. (CR S7641)
Dec 18, 2020
Message on Senate action sent to the House.
Dec 18, 2020
Received in the House.
Dec 18, 2020
Held at the desk.
  • February 3, 2020
    Introduced in Senate


  • February 3, 2020
    Read twice and referred to the Committee on Commerce, Science, and Transportation.


  • March 11, 2020
    Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment favorably.


  • September 30, 2020

    Latest Companion Bill Action

    HR 116-5373
    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.


  • November 17, 2020
    Committee on Commerce, Science, and Transportation. Reported by Senator Wicker with amendments. With written report No. 116-301.


  • November 17, 2020
    Placed on Senate Legislative Calendar under General Orders. Calendar No. 594.


  • December 17, 2020
    Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7642)


  • December 17, 2020
    Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.


  • December 17, 2020
    Measure laid before Senate by unanimous consent. (consideration: CR S7641-7642)


  • December 17, 2020
    The committee amendments withdrawn by Unanimous Consent. (CR S7641)


  • December 18, 2020
    Message on Senate action sent to the House.


  • December 18, 2020
    Received in the House.


  • December 18, 2020
    Held at the desk.
Jerry Moran

Jerry Moran

Republican Senator

Kansas

Cosponsors (1)
Richard Blumenthal (Democratic)

Commerce, Science, and Transportation Committee

Sports and Recreation

Related Bills

  • HR 116-5373: United States Anti-Doping Agency Reauthorization Act of 2020
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Alternative dispute resolution, mediation, arbitrationAthletesChild healthCongressional oversightCriminal investigation, prosecution, interrogationDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDue process and equal protectionInternational law and treatiesInternational organizations and cooperationMammalsMedical tests and diagnostic methodsOlympic gamesVeterinary medicine and animal diseases